Issue 16, 2022

Evaluating the therapeutic efficacy of nano-drugs targeting epidermal growth factor receptor

Abstract

Epidermal growth factor receptor (EGFR) targeted nano-drugs facilitate effective diagnosis and treatment of cancer. Herein, the therapeutic efficacy of nano-drugs targeting EGFR was evaluated from the perspective of cell entry efficiency and induced cell mechanical properties using force tracing and nano-indentation techniques at the single particle/cell level in real time.

Graphical abstract: Evaluating the therapeutic efficacy of nano-drugs targeting epidermal growth factor receptor

Supplementary files

Article information

Article type
Communication
Submitted
01 Dec 2021
Accepted
26 Jan 2022
First published
26 Jan 2022

Chem. Commun., 2022,58, 2726-2729

Evaluating the therapeutic efficacy of nano-drugs targeting epidermal growth factor receptor

J. Zhao, S. Li, X. Pang and Y. Shan, Chem. Commun., 2022, 58, 2726 DOI: 10.1039/D1CC06754K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements